Back to Results
First PageMeta Content
Clinical research / Drug Price Competition and Patent Term Restoration Act / Declaratory judgment / Generic drug / Abbreviated New Drug Application / Food and Drug Administration / Research exemption / Law / Pharmaceutical sciences / Civil procedure


Case 3:10-cv[removed]FLW -TJB Document[removed]Filed[removed]Page 1 of 20 PageID: 153 William J. O’Shaughnessy Jonathan M. H. Short
Add to Reading List

Document Date: 2014-12-17 12:00:26

Open Document

File Size: 114,77 KB

Share Result on Facebook

Company

WARNER CHILCOTT COMPANY LLC / Gould / Warner Chilcott Pharmaceuticals Inc. / Falls Co. / Novartis / Janssen Pharmaceutica N.V. / Dow Jones & Co. Inc. / Caraco Pharm / Eisai Co. / Roxane Laboratories Inc. / Defendants Par Pharmaceutical Inc. / USA Inc. / U.S.M.J. PAR PHARMACEUTICAL INC. / MedImmune Inc. / See Janssen Pharmaceutica N.V. / Plaintiffs Warner Chilcott Pharmaceuticals Inc. / PHARMACEUTICALS INC. / Apotex Inc. / Sepracor Inc. / Ventritex Inc. / Pfizer Inc. / Hatch-Waxman Act / Maryland Casualty Co. / Aetna / WARNER CHILCOTT / Holdings Inc. / Intermedics Inc. / CASES Abbott Labs. / Genentech Inc. / Teva / Alza Corp. / EMET PHARMACEUTICALS LLC / Dey L.P. / Oil Co. / Steel Co. / Jonathan M. H. Short McCarter & English LLP / A. Ainsworth COVINGTON & BURLING LLP / /

Country

United States / /

Event

FDA Phase / Legal Issues / Product Issues / Patent Issuance / Product Recall / /

/

IndustryTerm

drug product / generic drug product / federal law / generic drug manufacturers / /

Organization

Food and Drug Administration / Citizens for a Better Env’t / Mortensen / Medicare / Congress / UN Court / US Federal Reserve / FDA / /

Person

Paul A. Ainsworth / Freda L. Wolfson / /

/

Position

Secretary / D.J. / /

Product

Asacol / mesalamine / Abbreviated New Drug Application / ANDA / Approved Drug / Hatch-Waxman Act / Asacol® / /

ProvinceOrState

New Jersey / /

URL

http /

SocialTag